Table 2.
Type of thyroid dysfunction, n (%) | |
Hypothyroidism | 36 (17.3) |
Overt hypothyroidism | 29 (13.9) |
Subclinical hypothyroidism | 7 (3.4) |
Thyrotoxicosis | 12 (5.8) |
Overt thyrotoxicosis | 6 (2.9) |
Subclinical thyrotoxicosis | 6 (2.9) |
Isolated hypothyroxinemia | 3 (1.4) |
Isolated hyperthyroxinemia | 0 (0.0) |
Time to onset of thyroid dysfunction, median (IQR), months | |
Hypothyroidism | 3.5 (2.6–6.0) |
Thyrotoxicosis | 1.3 (1.2–2.7) |
Isolated hypothyroxinemia | 3.1 (2.2–5.0) |
Duration of thyroid dysfunction, median (IQR), months | |
Hypothyroidism | 8.4 (4.0–14.4) |
Thyrotoxicosis | 2.4 (1.8–4.2) |
Isolated hypothyroxinemia | 10.7 (10.1–12.7) |
Resolution of thyroid dysfunction, n (%) | |
Hypothyroidism | 4/36 (11.1) |
Thyrotoxicosis | 12/12 (100.0) |
Isolated hypothyroxinemia | 1/3 (33.3) |
CTCAE grade, n (%) | |
Grade 1 | 25 (49.0) |
Grade 2 | 26 (51.0) |
IQR, interquartile range; CTCAE, Common Terminology Criteria for Adverse Events.